|
Volumn 61, Issue 4, 2004, Pages 338-
|
New drug and biological product approvals, 2003
[No Author Info available]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
APREPITANT;
BORTEZOMIB;
CESIUM 137;
CONJUGATED ESTROGEN;
ENFUVIRTIDE;
ESTRADIOL;
ESTRADIOL PLUS LEVONORGESTREL;
ESTROGEN;
ETHINYLESTRADIOL;
ETHINYLESTRADIOL PLUS NORETHISTERONE ACETATE;
FERRIC FERROCYANIDE;
GEFITINIB;
GESTAGEN;
INFLUENZA VACCINE;
LEVONORGESTREL;
MEDROXYPROGESTERONE;
NORETHISTERONE;
PENTETATE CALCIUM TRISODIUM;
PENTETATE TRISODIUM ZINC;
PENTETATE ZINC;
PROTEASOME INHIBITOR;
PYRIDOSTIGMINE;
SILDENAFIL;
TADALAFIL;
THALLIUM;
UNCLASSIFIED DRUG;
VARDENAFIL;
CANCER CHEMOTHERAPY;
DRUG INDICATION;
DRUG MARKETING;
DRUG SCREENING;
ERECTILE DYSFUNCTION;
FOOD AND DRUG ADMINISTRATION;
INFECTION;
MILITARY MEDICINE;
NOTE;
PREMENOPAUSE;
PRIORITY JOURNAL;
|
EID: 85077297030
PISSN: 10792082
EISSN: None
Source Type: Journal
DOI: 10.1093/ajhp/61.4.338 Document Type: Note |
Times cited : (2)
|
References (0)
|